Tag:

ASC30

Type 2
Ascletis initiates participant dosing in Phase II trial of ASC30 for diabetes

by Salong Debbarma January 28, 2026

by Salong Debbarma January 28, 2026

Ascletis Pharma has dosed the first participants in a US Phase II trial of ASC30, an oral small molecule glucagon-like peptide-1 (GLP-1) receptor agonist, intended for treating type 2 diabetes …

DailyDiabetesNews.com, your ultimate destination for up-to-date and insightful information on diabetes, health tips, and living a fulfilling life with diabetes. Our mission is to empower and support individuals with diabetes, their loved ones, and the wider community by providing reliable, relevant, and engaging content that fosters a healthier and happier life.

Useful Links

Most Viewed Articles

The bitterness of sugar – Economic Times

The risks of unfair diabetes products and how to avoid them

8 best keto and low carb and calorie tracking apps

Latest Articles

Diabetic Neuropathy: Symptoms, Types, Causes, Treatment

Continuous glucose monitors linked to better blood sugar and kidney markers over three years

Study: Cats on vegan diets show lower rates of obesity

These 8 signs will tell you that the walking and diet you are doing is working! 8 diabetes reversal signs!

Daily Diabetes News is published by MatchingDonors.com.

Are you sure want to unlock this post?

Unlock left : 0

Are you sure want to cancel subscription?

Show/Hide Player

00:00

Queue

Update Required Flash plugin